pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
322
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
alectinib
Alecensa (alectinib)
Non-Small Cell Lung Cancer
F. Hoffmann-La Roche Ltd
Marketed
alemtuzumab
Campath (alemtuzumab)
B-Cell Chronic Lymphocytic Leukemia
Genzyme Corp
Marketed
allopurinol
Zyloprim (allopurinol)
Kidney Disease (Nephropathy)
Casper Pharma LLC
Marketed
← prev
page 6 of 11
next →
131
Pain
89
Neurology
1
alpelisib
Piqray (alpelisib)
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$NVS
NOVARTIS AG
Marketed
aminolevulinic acid hydrochloride
Ameluz (aminolevulinic acid hydrochloride)
Basal Cell Carcinoma (Basal Cell Epithelioma)
$BFRI
Biofrontera Inc.
Marketed
avapritinib
Ayvakit (avapritinib)
Gastrointestinal Stromal Tumor (GIST)
Blueprint Medicines Corp
Marketed
avutometinib potassium
avutometinib potassium
Fallopian Tube Cancer
$VSTM
Verastem, Inc.
Marketed
avutometinib potassium + defactinib hydrochloride
Avmapki Fakzynja (avutometinib potassium + defactinib hydrochloride)
Ovarian Cancer
$VSTM
Verastem, Inc.
Marketed
bacillus calmette-guerin [strain Montreal] vaccine
Pacis
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
Shire Pharmaceuticals Inc
Marketed
belinostat
Beleodaq (belinostat)
Peripheral T-Cell Lymphomas (PTCL)
Acrotech Biopharma Inc
Marketed
belzutifan
Welireg (belzutifan)
Renal Cell Carcinoma
$MRK
Merck & Co., Inc.
Marketed
bendamustine hydrochloride
Belrapzo (bendamustine hydrochloride)
B-Cell Non-Hodgkin Lymphoma
Eagle Pharmaceuticals Inc
Marketed
bexarotene
Targretin (bexarotene)
Cutaneous T-Cell Lymphoma
Bausch Health Americas Inc
Marketed
bicalutamide
Bicalutamide
Metastatic Prostate Cancer
Northstar Rx LLC
Marketed
binimetinib
Mektovi (binimetinib)
Metastatic Melanoma
Array BioPharma Inc
Marketed
bleomycin sulfate
Bleomycin Sulfate
Cervical Cancer
Northstar Rx LLC
Marketed
bosutinib
Bosutinib
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Alembic Pharmaceuticals Inc
Marketed
brigatinib
Alunbrig (brigatinib)
Non-Small Cell Lung Cancer
Takeda Pharmaceuticals USA Inc
Marketed
cabazitaxel
Jevtana (cabazitaxel)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sanofi-Aventis US LLC
Marketed
calaspargase pegol
Asparlas (calaspargase pegol)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Servier Pharmaceuticals LLC
Marketed
capmatinib hydrochloride
Tabrecta (capmatinib hydrochloride)
Non-Small Cell Lung Cancer
$NVS
NOVARTIS AG
Marketed
carfilzomib
Kyprolis (carfilzomib)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
$AMGN
AMGEN INC
Marketed
carmustine
Carmustine
Astrocytoma
STI Pharma LLC
Marketed
cetuximab
Erbitux (cetuximab)
Head And Neck Squamous Cell Carcinoma (HNSC)
Eli Lilly Interamerica Inc
Marketed
chlorambucil
Leukeran (chlorambucil [INN])
Chronic Lymphocytic Leukemia (CLL)
GlaxoSmithKline LLC
Marketed
ciltacabtagene autoleucel
Carvykti (ciltacabtagene autoleucel)
Refractory Multiple Myeloma
Janssen Biotech Inc
Marketed
cimetidine
Cimetidine
Acid Indigestion (Heartburn/Pyrosis)
L. Perrigo Company
Marketed
cimetidine hydrochloride
Cimetidine Hydrochloride
Duodenal Ulcer
Chartwell Pharmaceuticals LLC
Marketed
cobimetinib fumarate
Cotellic (cobimetinib fumarate)
Erdheim-Chester Disease (Erdheim–Chester Syndrome/ Polyos…
Genentech Inc
Marketed
copanlisib hydrochloride
Aliqopa (copanlisib hydrochloride)
Follicular Lymphoma
Bayer HealthCare Pharmaceuticals Inc
